Cargando…

Healthcare Costs Associated with Change in Body Mass Index in Patients with Type 2 Diabetes Mellitus in Spain: The ECOBIM Study

Background: Weight management is considered a key therapeutic strategy in type 2 diabetes mellitus. However, little is known about the impact of weight loss or body mass index (BMI) reduction on type 2 diabetes-related healthcare costs. Objective: The aim of this study was to estimate the economic i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dilla, Tatiana, Valladares, Amparo, Nicolay, Claudia, Salvador, Javier, Reviriego, Jesús, Costi, María
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2012
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269888/ https://www.ncbi.nlm.nih.gov/pubmed/23013427 http://dx.doi.org/10.1007/BF03261876

Ejemplares similares

Clinical characteristics of patients with type 2 diabetes mellitus at the time of insulin initiation: INSTIGATE observational study in Spain
por: Costi , María, et al.
Publicado: (2009)

Epidemiology, Quality of Life, and Costs Associated with Hypoglycemia in Patients with Diabetes in Spain: A Systematic Literature Review
por: Núñez, Mercedes, et al.
Publicado: (2019)

Health economics: the start of clinical freedom
por: Sacristán, José Antonio, et al.
Publicado: (2010)

Cost-effectiveness analysis of pemetrexed versus docetaxel in the second-line treatment of non-small cell lung cancer in Spain: results for the non-squamous histology population
por: Asukai, Yumi, et al.
Publicado: (2010)

Clinical Inertia in Poorly Controlled Type 2 Diabetes Mellitus Patients with Obesity: An Observational Retrospective Study
por: Romera, Irene, et al.
Publicado: (2019)

Cost effectiveness of ixekizumab versus secukinumab in the treatment of moderate-to-severe plaque psoriasis in Spain
por: Johansson, Erin, et al.
Publicado: (2018)

Cost-effectiveness analysis of baricitinib versus adalimumab for the treatment of moderate-to-severe rheumatoid arthritis in Spain
por: Schlueter, Max, et al.
Publicado: (2019)

Cost-effectiveness analysis of ixekizumab versus secukinumab in patients with psoriatic arthritis and concomitant moderate-to-severe psoriasis in Spain
por: Schweikert, Bernd, et al.
Publicado: (2020)

Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
por: Dilla, Tatiana, et al.
Publicado: (2014)

A modelled economic evaluation comparing atomoxetine with methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder in Spain
por: Hong, Jihyung, et al.
Publicado: (2009)

Analysis of Healthcare Costs Incurred in Regional Hospitals in Andalusia (Spain) during the COVID-19 Pandemic
por: Lopez-Villegas, Antonio, et al.
Publicado: (2022)

Pattern of healthcare resource utilization and direct costs associated with manic episodes in Spain
por: Tafalla, Monica, et al.
Publicado: (2010)

Antibiotic expected effectiveness and cost under real life microbiology: evaluation of ertapenem and ceftriaxone in the treatment of community-acquired pneumonia for elderly patients in Spain
por: Grau, Santiago, et al.
Publicado: (2014)

Body mass index and lifetime healthcare utilization
por: Edwards, Christina Hansen, et al.
Publicado: (2019)

Cost of severe hypoglycaemia in patients with type 1 diabetes in Spain and the cost-effectiveness of insulin lispro compared with regular human insulin in preventing severe hypoglycaemia
por: Reviriego, J, et al.
Publicado: (2008)

Costs and healthcare utilisation of patients with heart failure in Spain
por: Escobar, Carlos, et al.
Publicado: (2020)

Physician and patient management of type 2 diabetes and factors related to glycemic control in Spain
por: Yurgin, Nicole Rae, et al.
Publicado: (2008)

Body mass index and healthcare costs: using genetic variants from the HUNT study as instrumental variables
por: Edwards, Christina Hansen, et al.
Publicado: (2022)

Cost of Disorders of the Brain in Spain
por: Parés-Badell, Oleguer, et al.
Publicado: (2014)

Vitamin D Deficiency and Gestational Diabetes Mellitus in Relation to Body Mass Index
por: Agüero-Domenech, Nuria, et al.
Publicado: (2021)

Association between COVID-19 Vaccine Side Effects and Body Mass Index in Spain
por: Iguacel, Isabel, et al.
Publicado: (2021)

Costs and healthcare utilisation of patients with chronic kidney disease in Spain
por: Escobar, Carlos, et al.
Publicado: (2021)

Incidence of Diabetes in the Working Population in Spain: Results from the ICARIA Cohort
por: Vazquez, Luis Alberto, et al.
Publicado: (2018)

Occurrence of Leishmaniasis in Iberian Wolves in Northwestern Spain
por: Merino Goyenechea, Javier, et al.
Publicado: (2023)

Association of body mass index and osteoarthritis with healthcare expenditures and utilization
por: Johnston, Stephen S., et al.
Publicado: (2020)

Comparisons of Visceral Adiposity Index, Body Shape Index, Body Mass Index and Waist Circumference and Their Associations with Diabetes Mellitus in Adults
por: Wei, Junxiang, et al.
Publicado: (2019)

Are healthcare costs from obesity associated with body mass index, comorbidity or depression? Cohort study using electronic health records
por: Rudisill, C., et al.
Publicado: (2016)

Socioeconomic differences in body mass index in Spain: An intersectional multilevel analysis of individual heterogeneity and discriminatory accuracy
por: Hernández-Yumar, Aránzazu, et al.
Publicado: (2018)

Waist Circumference and Body Mass Index as Predictors of Health Care Costs
por: Højgaard, Betina, et al.
Publicado: (2008)

Healthcare use and costs associated with obesity in Badalona, Spain: a study protocol
por: Sicras-Mainar, Antonio, et al.
Publicado: (2012)

Descriptive analysis of childbirth healthcare costs in an area with high levels of immigration in Spain
por: Comas, Mercè, et al.
Publicado: (2011)

Economic burden of Cardiac Arrest in Spain: analyzing healthcare costs drivers and treatment strategies cost-effectiveness
por: Matilla-García, Mariano, et al.
Publicado: (2023)

Body mass index is associated with type 2 diabetes mellitus in Chinese elderly
por: Zhao, Qianping, et al.
Publicado: (2017)

Body mass index and stroke risk among patients with diabetes mellitus in Korea
por: Song, Do Kyeong, et al.
Publicado: (2022)

The Relation of CUN-BAE Index with Body Mass Index and Waist Circumference in Adults Aged 50 to 85 Years: The MCC-Spain Study
por: Davila-Batista, Veronica, et al.
Publicado: (2020)

The association between body mass index groups and metabolic comorbidities with healthcare and medication costs: a nationwide biobank and registry study in Finland
por: Vesikansa, Aino, et al.
Publicado: (2023)

Perceptions of Oncologists, Healthcare Policy Makers, Patients and the General Population on the Value of Pharmaceutical Treatments in Oncology
por: Sacristán, José A., et al.
Publicado: (2016)

Normative Values of Height, Bodyweight and Body Mass Index of 12–17 Years Population from Extremadura (Spain)
por: Gómez-Galán, Rafael, et al.
Publicado: (2021)

Impact of the COVID-19 Pandemic on Healthcare Activity in the Regional Hospitals of Andalusia (Spain)
por: Lopez-Villegas, Antonio, et al.
Publicado: (2022)

Body Mass Index Trajectories and Healthcare Utilization in Young and Middle-aged Adults
por: Elrashidi, Muhamad Y., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5c0bbpmvasgeh6q5c5nc2rdjct